12. Petrović D. Vojinović R, Lukić S, Novaković B, Mijailović M, Jagić N. Renovascular hypertension: diagnostic and therapy. Medicus 2005; 6(3): 39-42.
15. Granata A, Fiorini F, Andrulli S, Logias F, Galleni M, Romano G, Sicurezza E, Fiore CE. Doppler ultrasound and renal artery stenosis: An overview. J Ultrasound 2009; 12(4): 133-43.10.1016/j.jus.2009.09.006356745623397022
20. Rossi GP. A comprehensive review of the clinical aspects of primary aldosteronism. Nat Rev Endocrinol 2011; 7(8): 485-95.10.1038/nrendo.2011.7621610687
21. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenze-Roquelpo AP, Grossman AB, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metabolism 2007; 3(2): 92-102.10.1038/ncpendmet039617237836
22. Romero CA, Orias M, Weir M. Novel RAAS agonists and antagonists: clinical applications and controversies. Nat Rev Endocrinol 2015; 11: 242-52.10.1038/nrendo.2015.6709762225666495
23. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, et al. Use of Doppler Ultrasonography to predict the outcome therapy for renal arterystenosis. N Engl J Med 2001; 344(6): 410-7.10.1056/NEJM20010208344060311172177
25. Wiecek A, Chudek J, Adamczak M. Indications for renal revascularisation - the landscape after the ASTRAL study. Nephrol Dial Transplant 2010; 25(8): 2399-402.10.1093/ndt/gfq12020501462